News
InvestorsHub on MSN15h
Rocket Pharmaceuticals Shares Gain on FDA Green Light for Gene Therapy Targeting Heart FailureShares of Rocket Pharmaceuticals Inc (NASDAQ:RCKT) advanced 2.4% after the company announced that the U.S. Food and Drug ...
The Food and Drug Administration has approved Harliku (nitisinone) for the reduction of urine homogentisic acid in adult patients with alkaptonuria.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback